Clinical Trial Update: A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/II trial evaluating adebrelimab in combination with capecitabine and oxaliplatin for gastric cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: RECRUITING